GLP-1 medications are transforming obesity and diabetes care — and employer healthcare costs along the way. This session unpacks the data, trends, and considerations behind the decision to cover or limit access. Learn how leading employers are balancing clinical value, cost containment, and employee wellbeing in one of healthcare’s hottest debates.
